You are here

Home » Content

Renal Transplant Hastasında Geç Gelişen Sitomegalovirüs (CMV) İnfeksiyonu

Late Development of Cytomegalovirus (CMV) Infection in a Kidney Transplant Recipient

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Although more kidney transplant recipients are living longer with functioning grafts, exposure to pathogens while in a sustained immunosuppressive state places these patients at risk for a number of late-term infections. Risk for infections depends on the dose, duration, and timing of the immunosuppressant regimen, rather than the effects of a single immunosuppressant agent. Cytomegalovirus (CMVI infection commonly arises 1 to 4 months after transplantation. Here we report a kidney transplant recipient, in the fifth year of transplantation, developed a CMV pneumonia.
Bookmark/Search this post with
Abstract (Original Language): 
Organ transplantasyonu yapılan hastalar immünosupresİf tedavi nedeni ile infeksiyonlar açısından risk altındadır. Infeksiyon riski İmmünosupresİf tedavinin dozuna, süresine, içerisindeki ilaçların kendi etkilerine bağlı olarak değişkenlik gösterir. Sitomegalovirüs (CMV) enfeksiyonu sıklıkla transplantasyondan sonra 1-4. aylarda görülür. Renal transplantasyon yapılan olgumuz, transplantasyonun 5. yılında CMV pnömonisi gelişmesi üzerine sunulmaya değer bulundu.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_16_pp_198-200.pdf
  • 4
198-200
  • Turkish

REFERENCES

References: 

1. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751.
2. Rubin RH. Infectious disease complications of renal transplantation. Kidney Int 1993;44:221-236.
3. Jamil B, Nichoils K, Becker GJ, Walker RG. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 1999;68:1597-1603.
4. Kasiske BL, Vazquez MA, Harmon WE, et al. American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients, j Am Soc Nephrol 2000;1 Ksuppl 15>:S1-S86.
5. Unitred Network for Organ Sharing: UNOS Organ Procurement and Transplant Network (Ol'TNl data as of June 1, 2005.
6. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NH. Inifection in the renal transplant recipient. Am J Med 1981;70:405-411.
7. Kotton CN, Ryan ET, Fishman Ja. Prevention of infection in adult travelers after solid organ transplantation. Am J J'ranspiant 2005;5:8-14.
8. Rowshani AT, Bemelman FT, van Leeuwen F.M, van tier RA, ten Berge IJ. Clinical and immunologic aspects of cytomegalovinis infection in solid organ transplant recipients. Transplantation 2005;79:381-386.
9. Schvoerer E, Henriot S, Zachary P, et al. Monitoring low cytomegalovirus viremia in transplanted patients by a realtime PCR on plasma. J Med Virol 2005;76:76-81.
10. Piiparinen H, Ilöckerstedt K, Grönhagen-Kiska C. Latıtensclager I. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004;30:258-266.
11. Garrean S, Massad MG, Tshibaka M, Hanhan Z, Gaines AE, Benedetti E. Sirolimus-asscKİated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant 2005;19( 51:698-703.

Thank you for copying data from http://www.arastirmax.com